Brainstorm Cell Therapeutics BCLI
OTC BCLI
$0.81 -0.02 (-2.41%)
At close: Oct 15, 2026 · 4:00 PM EDT

Brainstorm Cell Therapeutics (BCLI) Revenue (2024 - 2026)

Updated

Analysis

Brainstorm Cell Therapeutics (BCLI) Revenue (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 25.31 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 16.99 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 15.38 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 15.03 Bn
10 Brainstorm Cell Therapeutics 8.72 Mn 8.65 Mn - -242,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -242,000.00
Mar 31, 2026 -81,000.00
Dec 31, 2025 -190,000.00
Sep 30, 2025 -59,000.00
Jun 30, 2025 -330,000.00
Mar 31, 2025 46,000.00
Dec 31, 2024 -66,000.00
Sep 30, 2024 -54,000.00
Jun 30, 2024 30,000.00
API Access

Brainstorm Cell Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=BCLI&period=max&api_key=YOUR_API_KEY